Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

CTI BioPharma (CTIC) News Today

CTI BioPharma logo
Q1 2024 Veracyte Inc Earnings Call
Connect Biopharma Holdings Ltd (CNTB)
Theravance Biopharma Inc TBPH
CTI Engineering Co Ltd (9621)
Sobi completes acquisition of CTI BioPharma Corp.
CTI BioPharma Corp. stock logo
1,405,859 Shares in CTI BioPharma Corp. (NASDAQ:CTIC) Purchased by AIGH Capital Management LLC
AIGH Capital Management LLC acquired a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,405,859 shares of the biopharmaceutical company's stock, valued at approximately $8,449,0
CTI BioPharma Corp. stock logo
Swiss National Bank Invests $1.33 Million in CTI BioPharma Corp. (NASDAQ:CTIC)
Swiss National Bank bought a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 221,000 shares of the biopharmaceutical company's st
Stifel Nicolaus upgrades CTI BioPharma (CTIC) to a Hold
CTI BioPharma Corp. stock logo
CTI BioPharma Corp. (NASDAQ:CTIC) Shares Sold by Blair William & Co. IL
Blair William & Co. IL lessened its stake in CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 24.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 132,413 shares of the biopharmaceutical company's stock after selling 43
CTI BioPharma Corp. stock logo
UBS Group AG Increases Stock Position in CTI BioPharma Corp. (NASDAQ:CTIC)
UBS Group AG boosted its stake in CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 542.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 926,309 shares of the biopharmaceutical company's st
CTI BioPharma Corp. stock logo
CTI BioPharma (NASDAQ:CTIC) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on CTI BioPharma in a research report on Friday. They set a "hold" rating for the company.
CTI BioPharma Corp. stock logo
Arizona State Retirement System Buys New Position in CTI BioPharma Corp. (NASDAQ:CTIC)
Arizona State Retirement System bought a new stake in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 25,821 shares of the biopharmaceutical company's s
CTI BioPharma Corp. stock logo
State Board of Administration of Florida Retirement System Invests $70,000 in CTI BioPharma Corp. (NASDAQ:CTIC)
State Board of Administration of Florida Retirement System acquired a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,580 shares o
JMP Securities Keeps Their Hold Rating on CTI BioPharma (CTIC)
CTI BioPharma Corp. stock logo
Sectoral Asset Management Inc. Acquires 12,000 Shares of CTI BioPharma Corp. (NASDAQ:CTIC)
Sectoral Asset Management Inc. raised its holdings in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 1.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 980,300 shares of the biopharmaceutical com
SVB Securities downgrades CTI BioPharma (CTIC) to a Hold
The Latest Analyst Ratings for CTI BioPharma
CTI BioPharma Corp. stock logo
CTI BioPharma Corp. (NASDAQ:CTIC) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) have been assigned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and six have given
Why Shares of CTI BioPharma Are Soaring Wednesday
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
Swedish Orphan Biovitrum AB To Acquire CTI BioPharma
Get CTI BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTIC and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

CTIC Media Mentions By Week

CTIC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CTIC
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

CTIC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CTIC Articles
This Week

0

0

CTIC Articles
Average Week

Get CTI BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTIC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CTIC) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners